A Systematic Review on Antimicrobial Resistance in Ghana from a One Health Perspective.

Eric S Donkor, Alex Odoom, Abdul-Halim Osman, Samuel Darkwah, Fleischer C N Kotey
Author Information
  1. Eric S Donkor: Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, Accra P.O. Box KB 4236, Ghana.
  2. Alex Odoom: Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, Accra P.O. Box KB 4236, Ghana. ORCID
  3. Abdul-Halim Osman: Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, Accra P.O. Box KB 4236, Ghana. ORCID
  4. Samuel Darkwah: Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, Accra P.O. Box KB 4236, Ghana. ORCID
  5. Fleischer C N Kotey: Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, Accra P.O. Box KB 4236, Ghana. ORCID

Abstract

BACKGROUND: Antimicrobial resistance (AMR) poses a global health threat, with lower-middle-income countries bearing a disproportionate burden. Surveillance of AMR under a One Health framework is needed to elucidate the associations among clinical, animal, and environmental AMR. This review aimed to describe the state of AMR in Ghana, focusing on One Health.
METHOD: This review utilized the PRISMA guidelines and major databases to systematically search and analyze AMR in Ghana published from 1 January 2014 to 1 May 2023.
RESULTS: Out of the 48 articles that met the inclusion criteria, 28 studies were conducted on humans, 14 studies involved animals, and 6 studies focused on the environment. A total of 48 different pathogens were identified across the human, animal, and environmental sectors, with the most common being (67%, = 32), spp. (52%, = 25), spp. (40%, = 19), and spp. (38%, = 18). Generally, a high prevalence of antibiotic resistance was observed among various bacterial species across the sectors. These bacteria exhibited resistance to commonly used antibiotics, with resistance to ampicillin and tetracycline exceeding 80%, and multidrug resistance (MDR) ranging from 17.6% in spp. to 100% in spp.
CONCLUSION: This review reaffirms the significant challenge of AMR in Ghana, with a high prevalence observed in the human, animal, and environmental sectors. Key pathogens (e.g., and ) found across the sectors emphasize the urgent need for a One Health approach to tackle AMR in Ghana.

Keywords

References

  1. Scientifica (Cairo). 2020 Dec 4;2020:6641461 [PMID: 33376622]
  2. Int J Food Sci. 2020 Nov 12;2020:8877196 [PMID: 33274191]
  3. Molecules. 2018 Mar 30;23(4): [PMID: 29601469]
  4. Front Cell Infect Microbiol. 2021 Dec 23;11:716299 [PMID: 35004340]
  5. BMC Microbiol. 2020 Aug 14;20(1):253 [PMID: 32795260]
  6. Sci Rep. 2022 Dec 21;12(1):22069 [PMID: 36543904]
  7. Int J Food Microbiol. 2022 Sep 2;376:109760 [PMID: 35661557]
  8. Microb Drug Resist. 2019 Dec;25(10):1449-1457 [PMID: 31237486]
  9. PLoS One. 2020 Aug 7;15(8):e0237263 [PMID: 32764812]
  10. Biomed Res Int. 2017;2017:4091856 [PMID: 28194411]
  11. BMC Health Serv Res. 2020 Oct 27;20(1):978 [PMID: 33109158]
  12. J Environ Public Health. 2022 Oct 6;2022:2850165 [PMID: 36246472]
  13. BMC Microbiol. 2023 Aug 7;23(1):212 [PMID: 37550643]
  14. Pan Afr Med J. 2022 Mar 30;41:259 [PMID: 35734329]
  15. Environ Health Insights. 2022 Oct 22;16:11786302221130613 [PMID: 36311334]
  16. Vet Res Commun. 2024 Apr 1;: [PMID: 38556573]
  17. Int J Environ Res Public Health. 2022 Sep 28;19(19): [PMID: 36231603]
  18. Microbiol Insights. 2022 Apr 29;15:11786361221093278 [PMID: 35521227]
  19. BMJ. 2021 Mar 29;372:n71 [PMID: 33782057]
  20. Healthcare (Basel). 2023 Jul 05;11(13): [PMID: 37444780]
  21. Lancet. 2022 Feb 12;399(10325):629-655 [PMID: 35065702]
  22. Animals (Basel). 2020 Nov 29;10(12): [PMID: 33260303]
  23. Antibiotics (Basel). 2021 Aug 24;10(9): [PMID: 34572614]
  24. Antimicrob Resist Infect Control. 2017 May 10;6:44 [PMID: 28491294]
  25. Pathogens. 2022 Nov 17;11(11): [PMID: 36422621]
  26. Infect Immun. 2020 Oct 19;88(11): [PMID: 32839189]
  27. PLoS One. 2023 Mar 10;18(3):e0282835 [PMID: 36897838]
  28. Diseases. 2018 Jul 19;6(3): [PMID: 30029549]
  29. Trop Med Health. 2017 Feb 10;45:3 [PMID: 28194090]
  30. Front Microbiol. 2022 Nov 04;13:983047 [PMID: 36406391]
  31. Int J Environ Res Public Health. 2022 Aug 22;19(16): [PMID: 36012083]
  32. Trop Med Infect Dis. 2019 Sep 03;4(3): [PMID: 31484298]
  33. BMC Public Health. 2017 Nov 23;17(1):896 [PMID: 29169340]
  34. BMJ Glob Health. 2019 Nov 10;4(6):e002104 [PMID: 31799007]
  35. Health Policy Plan. 2016 Mar;31(2):250-8 [PMID: 26045328]
  36. Antimicrob Resist Infect Control. 2018 Mar 9;7:37 [PMID: 29541448]
  37. PLOS Glob Public Health. 2022 May 16;2(5):e0000417 [PMID: 36962199]
  38. Int J Environ Res Public Health. 2022 Oct 10;19(19): [PMID: 36232262]
  39. Int J Microbiol. 2017;2017:9509087 [PMID: 29038662]
  40. Trop Med Infect Dis. 2021 May 14;6(2): [PMID: 34068850]
  41. Infect Drug Resist. 2020 Dec 24;13:4653-4662 [PMID: 33380815]
  42. Epidemiol Infect. 2016 Nov;144(15):3288-3299 [PMID: 27334298]
  43. Front Cell Infect Microbiol. 2021 Nov 25;11:771510 [PMID: 34900756]
  44. Emerg Infect Dis. 2018 May;24(5):916-919 [PMID: 29664368]
  45. Foodborne Pathog Dis. 2019 May;16(5):352-358 [PMID: 30907631]
  46. Res Synth Methods. 2021 Jan;12(1):55-61 [PMID: 32336025]
  47. Foods. 2021 Apr 21;10(5): [PMID: 33919142]
  48. Vet Microbiol. 2018 Apr;217:7-12 [PMID: 29615260]
  49. Infect Drug Resist. 2017 Jun 13;10:175-183 [PMID: 28652785]
  50. Interact J Med Res. 2023 Mar 21;12:e41190 [PMID: 36943329]
  51. Ghana Med J. 2021 Dec;55(4):298-307 [PMID: 35957938]
  52. Int J Environ Res Public Health. 2022 Sep 01;19(17): [PMID: 36078645]
  53. Psychol Methods. 2006 Jun;11(2):193-206 [PMID: 16784338]
  54. Antibiotics (Basel). 2022 Dec 13;11(12): [PMID: 36551465]
  55. Microbiol Insights. 2023 Jan 28;16:11786361221150695 [PMID: 36726578]
  56. BMJ. 2019 Aug 28;366:l4898 [PMID: 31462531]
  57. Heliyon. 2022 Aug 30;8(9):e10431 [PMID: 36097488]
  58. Microorganisms. 2022 Apr 06;10(4): [PMID: 35456830]
  59. Pan Afr Med J. 2017 Feb 02;26:60 [PMID: 28451037]
  60. Vet Res. 2021 Feb 8;52(1):16 [PMID: 33557913]
  61. Antibiotics (Basel). 2023 Jun 15;12(6): [PMID: 37370379]
  62. Antimicrob Resist Infect Control. 2020 Nov 7;9(1):181 [PMID: 33160396]
  63. J Pathog. 2021 Mar 04;2021:6648247 [PMID: 33747569]
  64. BMC Res Notes. 2018 Apr 25;11(1):254 [PMID: 29695265]
  65. BMC Infect Dis. 2014 Dec 21;14:3857 [PMID: 25528352]
  66. One Health Outlook. 2021 Oct 19;3(1):18 [PMID: 34663477]
  67. PLoS One. 2019 Oct 10;14(10):e0223598 [PMID: 31600300]
  68. Front Microbiol. 2022 May 19;13:894319 [PMID: 35663873]
  69. Saudi J Biol Sci. 2015 Jan;22(1):90-101 [PMID: 25561890]
  70. One Health Outlook. 2020 Aug 18;2:12 [PMID: 33829133]
  71. Microbiol Insights. 2022 Jun 24;15:11786361221106109 [PMID: 35769634]
  72. Parasite. 2021;28:16 [PMID: 33739262]
  73. BMC Infect Dis. 2019 Jan 21;19(1):76 [PMID: 30665342]
  74. BMC Infect Dis. 2016 Nov 29;16(1):720 [PMID: 27899074]
  75. Indian J Med Res. 2019 Feb;149(2):119-128 [PMID: 31219076]
  76. PLoS One. 2022 Dec 30;17(12):e0279715 [PMID: 36584159]
  77. Biomedicines. 2023 Apr 19;11(4): [PMID: 37189839]
  78. Int J Environ Res Public Health. 2020 Apr 28;17(9): [PMID: 32354184]
  79. Antibiotics (Basel). 2023 Jan 27;12(2): [PMID: 36830166]
  80. Antibiotics (Basel). 2022 Jan 17;11(1): [PMID: 35052997]
  81. Pathogens. 2022 Dec 11;11(12): [PMID: 36558851]
  82. Vet World. 2022 Mar;15(3):743-749 [PMID: 35497962]
  83. Pan Afr Med J. 2022 Dec 27;43:207 [PMID: 36942137]
  84. Int J Environ Res Public Health. 2022 Dec 09;19(24): [PMID: 36554436]

Word Cloud

Created with Highcharts 10.0.0AMRresistanceGhanaOneHealthsppanimalreviewsectors=healthenvironmentalstudiesacrosshumanAntimicrobialamong148environmentpathogenshighprevalenceobservedmultidrugMDRBACKGROUND:posesglobalthreatlower-middle-incomecountriesbearingdisproportionateburdenSurveillanceframeworkneededelucidateassociationsclinicalaimeddescribestatefocusingMETHOD:utilizedPRISMAguidelinesmajordatabasessystematicallysearchanalyzepublishedJanuary2014May2023RESULTS:articlesmetinclusioncriteria28conductedhumans14involvedanimals6focusedtotaldifferentidentifiedcommon67%3252%2540%1938%18Generallyantibioticvariousbacterialspeciesbacteriaexhibitedcommonlyusedantibioticsampicillintetracyclineexceeding80%ranging176%100%CONCLUSION:reaffirmssignificantchallengeKeyegfoundemphasizeurgentneedapproachtackleSystematicReviewResistancePerspectiveantimicrobialsurveillancesystematic

Similar Articles

Cited By